ストックスクリーナーアプリを入手
0.7056
4.65%
-0.0344
Tela Bio Inc (TELA) 最新ニュース
TELA Bio, Inc. Actuals & Estimates (NASDAQ:TELA) - TradingView
TELA Bio, Inc. Actuals & Estimates (BOATS:TELA) - TradingView
TELA Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
Price to sales forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
TELA Bio Inc (TELA) Valuation: PE, PB & Fair Value Analysis - TradingKey
TELA Bio Inc (TELA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TELA Bio Inc (TELA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TELA Bio Inc (TELA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TELA Stock Price, Quote & Chart - ChartMill
TELA Bio Inc (TELA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TELA Bio Inc (TELA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TELA Bio Inc (TELA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TELA Bio Inc (TELA) Institutional Confidence - TradingKey
TELA Bio Inc (TELA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TELA Bio Inc. (TELA) Slides 5.7% as Shares Approach Critical Support at $0.82Volatility Breakout Picks - newsline.com
TELA Bio (TELA) grants director new RSUs and stock options - Stock Titan
TELA Bio (NASDAQ: TELA) director Guido Neels granted stock and long-term options - Stock Titan
TELA Bio (NASDAQ: TELA) grants director new stock and options - Stock Titan
Joseph H. Capper joins TELA Bio (TELA) board and files initial insider report - Stock Titan
TELA Bio (TELA) director awarded 11,675 shares and options for 17,335 - Stock Titan
Director Guido J. Neels files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
TELA Bio : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
TELA Bio (NASDAQ: TELA) director Thomas Paul files initial Form 3 ownership - Stock Titan
TELA Bio (TELA) director Paul Thomas receives RSU and option grants - Stock Titan
Director Guy P. Nohra files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
TELA Bio Shareholders Expand Equity Incentive Plan Authorization - TipRanks
TELA Bio (NASDAQ: TELA) OKs 3.5M-share incentive plan boost - Stock Titan
TELA Bio Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesRevenue Recognition Risk - newsline.com
EW Healthcare Partners Fund 2-UGP Secures Board Seat at TELA Bio with 17.23% Stake - TradingView
EW Healthcare funds report 7.7M TELA Bio (TELA) shares and board seat - Stock Titan
TELA Bio Inc Annual Shareholders Meeting Transcript - GuruFocus
TELA Q1 2026 Earnings: EPS Miss Sends Stock Slightly LowerRevenue Inflection Point - newsline.com
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - MSN
TELA Bio | 8-K: Current report - Moomoo
TELA Bio Expands Europe Sales as U.S. Growth Slows - MyChesCo
TELA Bio Inc. (TELA) Edges Lower, Tests Key Support After 2.7% DeclineUser Trade Ideas - Newser
Tela Bio Eyes Second-Half Ramp After Mixed Quarter - TipRanks
TELA Bio (TELA) Q1 2026 Results Miss Estimates — EPS $-0.21 vs $-0.19Retail Earnings Report - Newser
TELA Bio Healthcare Story Faces New Market Scrutiny - Kalkine Media
TELA Bio (NASDAQ: TELA) holder reports 2.44M shares, 5.5% stake - Stock Titan
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25 - Yahoo Finance
About Us | Oil & Gas JournalTELA Bio, Inc.Common stock (Nasdaq:TELA) Stock Quote - FinancialContent
Becton Dickinson stock (US0718131099): Antitrust case survives dismissal - AD HOC NEWS
TELA Bio, Inc. (TELA) reports Q1 loss, beats revenue estimates - MSN
Lake Street Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA) - The Globe and Mail
Tela Bio Earnings Call Balances Momentum and Risk - TipRanks
TELA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Becton Hernia Mesh Antitrust Case Survives Dismissal - Law360
TELA Bio (NASDAQ: TELA) Q1 2026 revenue edges up as net loss widens - Stock Titan
TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M - MSN
Q1 2026 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio revenue up 3% to USD 19.1M in Q1 2026 - Medical Buyer
TELA Bio, Inc. (NASDAQ:TELA) Q1 2026 Earnings Call Transcript - Insider Monkey
TELA Bio, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
2.35%
0.70%
大文字化:
|
ボリューム (24 時間):